- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Impaired Fasting Glucose, Newly-diagnosed Type 2 Diabetes in Germany
Total 684 results
-
Prof. Dr. med. Andreas F. H. PfeifferEuropean UnionCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
Technische Universität DresdenUnknownDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Australia
-
German Institute of Human NutritionCalifornia Walnut Commission; German Center for Diabetes Research; Institute...UnknownHypertension | Obesity | Metabolic Syndrome | Type 2 Diabetes | Dyslipidemia | NAFLDGermany
-
German Diabetes CenterCompletedType 2 Diabetes | Fatty Liver, NonalcoholicGermany
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
University of HohenheimInstitut für Mikroökologie GmbHCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
German Institute of Human NutritionGerman Center for Diabetes Research; Institute for Cereal Processing GmbH/Institut... and other collaboratorsUnknownHypertension | Obesity | Type 2 Diabetes | NAFLD | DyslipoproteinaemiaGermany
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany, Hungary
-
SanofiCompletedType 2 Diabetes MellitusFrance, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusCzech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
-
GlaxoSmithKlineCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Johannes Gutenberg University MainzBoehringer IngelheimCompletedDiabetes Mellitus, Type 2 | Diastolic DysfunctionGermany
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
MedImmune LLCCompleted
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Germany
-
Eli Lilly and CompanyActive, not recruitingDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimCompleted
-
AstraZenecaParexelCompleted
-
Eli Lilly and CompanyCompleted
-
BayerCompletedDiabetes Mellitus, Type 2Germany
-
BayerCompletedDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy VolunteersGermany
-
SanofiProfil GmbH, Neuss, GermanyCompletedDiabetes Mellitus, Type 2Germany
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Germany, Switzerland
-
German Cancer Research CenterGerman Federal Ministry of Education and Research; Heidelberg UniversityCompletedType 2 Diabetes MellitusGermany
-
Diamontech AGInstitut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft...TerminatedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Germany
-
University of JenaCompletedDecreased Cardovascular Risk | Decreased Risk of Diabetes Mellitus Type IIGermany
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
-
Bristol-Myers SquibbCompletedType 2 Diabetes MellitusSouth Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery SystemsGermany
-
NovartisCompletedVildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States, Germany
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Germany
-
University of GiessenComenius University; Sportpark Zwickau, Germany; Sportpark Glauchau, GermanyCompletedDiabetes | Diabetes Mellitus, Non-Insulin-DependentGermany
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
NovartisCompletedType 2 Diabetes MellitusRussian Federation, Germany, United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy VolunteersGermany